Home / Guides / Metformin vs. semaglutide

Pill, shot, or both?

Metformin vs. semaglutide: what’s different, and can you take both?

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

Generic metformin is $9 a month at the starting dose, no coupon needed (November 1, 2026); Ozempic, semaglutide for diabetes, was tested alongside it. For weight, the Wegovy pen is $199 for each of a new patient’s first two fills (through Dec. 31, 2026), then $349 a month, or $399 at 7.2 mg; compounded semaglutide, not FDA-approved, is $95 at NexLife on the 12-month plan, or $109 month to month.

  • Metformin: a generic pill, approved since 1995
  • Ozempic: a weekly shot or daily tablet, for type 2 diabetes
  • Together: Ozempic was tested in people taking metformin
NexLifeSame price at every dose
Illustration of a compounded semaglutide vial

$95/mo on a 12-month plan, all-inclusive, same price at every dose

Or $109/mo month to month

Brand-name Wegovy pen: $349 a month self-pay ($399 for HD)

Check my eligibility

About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication

See all 4 plans and what a year costs
Compounded semaglutide, all in, the same price at every dose
PlanPer month12 months at this rate
12-month Most savings$95$1,140
6-month$99$1,188
3-month$105$1,260
Month to month$109$1,308

Month to month costs $168 more over 12 months than the 12-month plan. Plans renew until you cancel. Month to month is billed monthly. The 3-, 6- and 12-month plans are paid upfront at checkout: $315, $594 or $1,140.

Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 1, 2026)LegitScript-certified

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.

  • Licensed U.S. providers
  • LegitScript certified
  • Free expedited shipping
  • HSA, FSA, Affirm, Klarna, Afterpay
  • 24/7 support, real people
  • Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)

Compounded semaglutide isn’t FDA-approved, isn’t a generic, and isn’t Ozempic or Wegovy. A licensed provider prescribes it only when it offers a significant difference for you.

At a glance

Metformin vs. semaglutide at a glance: weight, A1c and cost

Separate trials, not head-to-head. Prices checked November 1, 2026.

Metformin vs. semaglutide at a glance: what each is, weight and A1c in separate trials, taking both, approval for weight loss, and self-pay prices checked November 1, 2026
QuestionAnswer
What is each?Metformin is a blood-sugar pill, in use since 1995. Semaglutide is a GLP-1 medicine: Ozempic for type 2 diabetes, Wegovy for weight.
Which lowers weight more?Semaglutide, in separate trials: 14.9% average loss on Wegovy at 68 weeks (STEP 1); compounded semaglutide wasn’t studied. In metformin’s 29-week trial, placebo lost slightly more.
Which lowers A1c more?About the same, in separate trials: 1.4 points on metformin at 29 weeks; 1.4 to 1.6 on Ozempic at 30 weeks (SUSTAIN 1).
Can you take both?For type 2 diabetes, yes, if prescribed: Ozempic was tested in people already taking metformin.
Approved for weight loss?Only Wegovy. Metformin and Ozempic are approved for type 2 diabetes; for weight alone, both are off-label.
Self-pay price?Metformin: $9 for a starting month on GoodRx. Ozempic pens: $349 a month ($499 at 2 mg). Checked November 1, 2026.
  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • Metformin vs. semaglutide: similar A1c drops in separate trials, but semaglutide lowered weight far more: Wegovy averaged 14.9% at 68 weeks.
  • For type 2 diabetes, you can take both, if prescribed. Ozempic was tested in people already taking metformin.
  • Only semaglutide has a weight-loss brand: Wegovy. Metformin and Ozempic are approved for type 2 diabetes; for weight alone, both are off-label.
  • For prediabetes, neither is FDA-approved. In the Diabetes Prevention Program (2002), metformin cut new cases 31% versus placebo.
  • Metformin costs far less: $9 for a starting month on GoodRx. Ozempic pens are $349 a month self-pay, $499 at 2 mg.
  • Compounded semaglutide isn’t FDA-approved or a type 2 diabetes treatment. At NexLife, it’s $95 a month on the 12-month plan.

At a glance

How are metformin and semaglutide different?

Metformin is a generic pill for type 2 diabetes. Semaglutide is a GLP-1 medicine, sold as Ozempic for diabetes and Wegovy for weight.

From the labels (metformin, Ozempic, Ozempic tablets and Wegovy) and the DPP paper, read Nov. 12, 2026, and from Novo Nordisk, GoodRx and Medicare.gov, checked November 1, 2026. Separate trials, not head-to-head. Medicare’s $274 is what Medicare pays, not your copay. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied.
MetforminOzempic (semaglutide)Wegovy (semaglutide)
What it isA blood-sugar pill (a biguanide), sold as a genericA GLP-1 medicine from Novo NordiskA GLP-1 medicine from Novo Nordisk
FDA-approved forType 2 diabetes in adults and children 10 and older (since 1995)Type 2 diabetes in adults, plus lowering heart and kidney risks in some of them (since 2017)Weight in adults and children 12 and older, heart risk in adults with heart disease, and MASH (since 2021)
How you take itTablets by mouth, once to three times a day, with mealsA shot under the skin once a week, or a daily tablet (Ozempic tablets)A weekly shot, or a pill (30 tablets a month)
Dose range500 mg to 2,550 mg a day (2,000 mg for children)0.25 mg to 2 mg a week; tablets 1.5, 4 or 9 mg a day0.25 mg to 2.4 mg a week; 7.2 mg (Wegovy HD) for some adults
Main trialname and yearDiabetes Prevention Program (NEJM, 2002): 31% fewer new cases of diabetes than placebo, in adults at high riskSUSTAIN 1 (2017): A1c down 1.4 to 1.6 points at 30 weeks, vs 0.1 on placeboSTEP 1 (2021): 14.9% average weight loss at 68 weeks, vs 2.4% on placebo
Most common side effectslabel trials, vs placeboDiarrhea 53% (12%), nausea or vomiting 26% (8%)Nausea 15.8% to 20.3% (6.1%), diarrhea 8.5% to 8.8% (1.9%)Nausea 44% (16%), diarrhea 30% (16%), vomiting 24% (6%)
Boxed warningLactic acidosisThyroid C-cell tumors, seen in rodentsThyroid C-cell tumors, seen in rodents
Self-pay pricechecked November 1, 2026$9 for 60 tablets of 500 mg on GoodRx, Walmart’s regular price (no coupon needed)Pens $349 a month ($499 at 2 mg) at NovoCare, $199 for each of a new patient’s first two fills through December 31, 2026; tablets $149 to $299$349 a month for the pen ($399 for HD); the pill $149 to $299
Insurance and Medicare, 2026–2027A generic: your plan sets the copayPart D plans may cover it for type 2 diabetes. From January 1, 2027, Medicare pays $274 for a 30-day supplyMedicare’s GLP-1 Bridge: $50 a month if you qualify, through December 31, 2027, but not with type 2 diabetes

NexLife Price Match Guarantee†. Already on compounded semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

Swipe the table sideways to see every column.

From the labels (metformin, Ozempic, Ozempic tablets and Wegovy) and the DPP paper, read Nov. 12, 2026, and from Novo Nordisk, GoodRx and Medicare.gov, checked November 1, 2026. Separate trials, not head-to-head. Medicare’s $274 is what Medicare pays, not your copay. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied.

Which fits you

Metformin or semaglutide: which is right for you?

It depends on what you’re treating, your other conditions and your budget. Six common situations:

  • If you were just diagnosed with type 2 diabetes

    Both are approved for it. Metformin is a pill in use since 1995, $9 for a starting month, no coupon needed. Ozempic is a weekly shot or a daily tablet. Your provider weighs your A1c, kidneys and other conditions.

  • If you have heart or kidney disease too

    Ozempic’s label adds two uses metformin’s lacks: lowering the risk of heart attack, stroke and heart-related death with heart disease, and of kidney decline with chronic kidney disease, in adults with type 2 diabetes.

  • If weight loss is your main goal

    Neither metformin nor Ozempic is FDA-approved for weight loss. Wegovy is: for adults with obesity, or overweight with a weight-related condition. Using metformin or Ozempic for weight alone is off-label.

  • If you have prediabetes

    Neither is approved for it. Metformin has the long-term trial, the DPP, where a lifestyle program did better still. With Medicare and a BMI of 27 or more, prediabetes can qualify you for Wegovy at $50 a month through the GLP-1 Bridge.

  • If cost is the barrier

    Generic metformin is the low-cost option by far. For type 2 diabetes, Ozempic pens are $349 a month self-pay, and Ozempic tablets $149 to $299. For weight loss, the Wegovy pen is also $349, and compounded semaglutide, which isn’t FDA-approved, costs less. Every price is in the cost table below.

  • If needles are the problem

    Metformin is a pill, and so is semaglutide for type 2 diabetes: Ozempic tablets (new in 2026; $149 to $299 for 30 tablets at NovoCare, by dose) and Rybelsus. For weight, there’s the Wegovy pill, also $149 to $299 a month self-pay. More: GLP-1 pills vs. injections.

Your provider decides which medicine fits, and at what dose.

Step by step

How do you choose between metformin and semaglutide?

Start with what you’re treating, then weigh your other conditions, the evidence and the cost. Your provider decides which medicine fits, and at what dose.

  1. Name what you’re treating. For type 2 diabetes, metformin and Ozempic are both approved. For weight loss, Wegovy is the approved semaglutide; using metformin or Ozempic for weight alone is off-label. Neither is approved for prediabetes.
  2. Weigh your other conditions. Ozempic’s label adds two uses metformin’s lacks for adults with type 2 diabetes: cutting heart risks with heart disease and kidney risks with chronic kidney disease. Metformin’s label sets kidney limits, so your eGFR is checked first.
  3. Compare the trial results. In separate trials, A1c fell similarly: 1.4 points on metformin at 29 weeks and 1.4 to 1.6 on Ozempic at 30 weeks (SUSTAIN 1). For weight, Wegovy averaged 14.9% at 68 weeks (STEP 1). Compounded semaglutide wasn’t studied.
  4. Weigh the side effects. Both mostly affect the stomach: 53% had diarrhea on metformin (12% on placebo), and 20.3% nausea on Ozempic 1 mg (6.1%), per the metformin and Ozempic labels. Metformin’s boxed warning is lactic acidosis; semaglutide’s is thyroid C-cell tumors, seen in rodents.
  5. Compare the cost. Generic metformin is $9 for a starting month on GoodRx, and Ozempic pens $349 a month self-pay ($499 at 2 mg). Compounded semaglutide isn’t FDA-approved; at NexLife, it’s $95 a month on the 12-month plan or $109 month to month.
  6. Decide with your provider. Your provider decides whether to add one to the other; for type 2 diabetes, Ozempic was tested in people already taking metformin. Compounded semaglutide isn’t a type 2 diabetes treatment. Don’t start, stop or change a dose on your own.

The trials were separate, not head-to-head, and prices were checked November 1, 2026.

Results

Metformin or semaglutide: which lowers blood sugar and weight more?

In separate trials, both lowered A1c by similar amounts, and semaglutide lowered weight much more. No trial in either label compares the two directly.

Separate trials with different people, lengths and doses. Metformin and Ozempic: their FDA labels (Glucophage, May 2018; Ozempic, May 2026). Wegovy: its June 2026 label, where STEP 1 and STEP 2 are Studies 2 and 3. Years are the journal publications: SUSTAIN 1 and SUSTAIN FORTE in The Lancet Diabetes & Endocrinology, STEP 1 in The New England Journal of Medicine, STEP 2 in The Lancet. Pounds are converted from kilograms. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied.
TrialWho took partA1c changeWeight change
Metformin, label trial29 weeksAdults with type 2 diabetes and obesity, on diet alone−1.4 points (placebo +0.4)−1.4 lb (placebo −2.4 lb)
Ozempic, SUSTAIN 130 weeks; 2017Adults with type 2 diabetes on no other diabetes medicine−1.4 on 0.5 mg, −1.6 on 1 mg (placebo −0.1)−3.8 kg (8.4 lb) and −4.7 kg (10.4 lb); placebo −1.2 kg (2.6 lb)
Ozempic 2 mg vs 1 mg, SUSTAIN FORTE40 weeks; 2021Adults taking metformin, some with a sulfonylurea−2.1 on 2 mg, −1.9 on 1 mg−6.4 kg (14.1 lb) and −5.6 kg (12.3 lb)
Wegovy, STEP 168 weeks; 2021Adults with obesity or overweight, without diabetesNot its main measure−14.9% (placebo −2.4%)
Wegovy, STEP 268 weeks; 2021Adults with type 2 diabetes and overweight or obesityNot its main measure−9.6% (placebo −3.4%)

Swipe the table sideways to see every column.

Separate trials with different people, lengths and doses. Metformin and Ozempic: their FDA labels (Glucophage, May 2018; Ozempic, May 2026). Wegovy: its June 2026 label, where STEP 1 and STEP 2 are Studies 2 and 3. Years are the journal publications: SUSTAIN 1 and SUSTAIN FORTE in The Lancet Diabetes & Endocrinology, STEP 1 in The New England Journal of Medicine, STEP 2 in The Lancet. Pounds are converted from kilograms. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied.

The difference is weight. A1c fell 1.4 points in metformin’s 29-week trial and 1.4 to 1.6 points in SUSTAIN 1 (2017), and 2.1 points on Ozempic 2 mg in people already on metformin (SUSTAIN FORTE, 2021). In metformin’s trial, placebo lost slightly more weight; Ozempic and Wegovy lowered it clearly.

Heart and kidneys. Ozempic’s label also reports SUSTAIN 6 (2016), a heart-outcomes trial in 3,297 adults with type 2 diabetes, and FLOW (2024), a kidney-outcomes trial in 3,533 adults with type 2 diabetes and kidney disease. Metformin’s label has no heart or kidney use. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied.

Taking both

Can you take metformin and semaglutide together?

For type 2 diabetes, yes, under a provider’s care: Ozempic was tested in people already taking metformin, and the labels say where the risks are. Without diabetes, metformin for weight loss is off-label.

  1. What the trials did

    Ozempic was added for people already on metformin, some also on another diabetes pill, and compared with sitagliptin or exenatide for 56 weeks and with insulin glargine for 30 weeks. Its 2 mg dose was tested against 1 mg the same way, for 40 weeks, and a fifth trial added it to basal insulin, with or without metformin, for 30 weeks.

  2. Low blood sugar

    Both labels tie the risk to insulin and sulfonylureas. Ozempic’s says adding it to them raises the risk, including severe lows, and to consider lowering their dose. Metformin’s says the same about insulin and drugs that make the body release more insulin, such as sulfonylureas.

  3. Your kidneys

    Metformin’s label sets limits: check your eGFR before you start; starting isn’t recommended at an eGFR of 30 to 45, and metformin is stopped below 30. Ozempic’s label warns that dehydration from vomiting or diarrhea can injure the kidneys.

Who decides? Your provider: whether to add one to the other, which dose, and when. Don’t start, stop or change a dose on your own. NexLife’s providers prescribe compounded semaglutide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace metformin, Ozempic or your diabetes care. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied. More: getting a semaglutide prescription.

Prediabetes

Metformin or semaglutide for prediabetes?

Neither is FDA-approved for prediabetes. Metformin has the best-known trial, the Diabetes Prevention Program (NEJM, 2002).

  • 31%fewer new cases of diabetes on metformin than on placeboDPP, NEJM 2002; about 2.8 years
  • 58%fewer with the lifestyle programgoal: 7% weight loss and 150 minutes of activity a week (DPP)
  • 13.9people on metformin for 3 years to prevent one case6.9 in the lifestyle program (DPP)

Who was in it. The DPP enrolled 3,234 adults without diabetes whose blood sugar was high when fasting and after a glucose drink. Metformin was 850 mg twice a day, and the researchers concluded the lifestyle program worked better.

Semaglutide. Wegovy is approved for weight in adults with obesity, or overweight with a weight-related condition. Prediabetes isn’t one of its listed uses, and Ozempic’s approvals are for type 2 diabetes.

With Medicare? The GLP-1 Bridge counts prediabetes with a BMI of 27 or more as a qualifying condition for Wegovy, at $50 a month through December 31, 2027.

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

Medicare.gov (Centers for Medicare & Medicaid Services), Weight loss drugs

People with type 2 diabetes can’t use the Bridge; their Part D plan may cover a GLP-1 for diabetes. Medicare and GLP-1s.

“You aren't eligible if you: … Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s).”

Medicare.gov (Centers for Medicare & Medicaid Services), Weight loss drugs

Weight loss

Can you use metformin or Ozempic for weight loss?

Not on label: both are approved for type 2 diabetes, not weight loss. Semaglutide’s weight-loss brand is Wegovy.

Metformin. Its label lists no weight-loss use, so using it for weight loss is off-label. In its adult trial, people on it lost 1.4 lb at 29 weeks, against 2.4 lb on placebo; in children 10 to 16 with type 2 diabetes, 3.3 lb against 2.0 lb at 16 weeks.

Ozempic. It lowered weight in its diabetes trials, but prescribing it for weight loss alone is off-label.

Wegovy. The semaglutide approved for weight, at up to 2.4 mg a week (7.2 mg for some adults). Its results are in the table above. These trials studied FDA-approved Ozempic and Wegovy; compounded semaglutide wasn’t studied.

PCOS. Neither metformin nor any semaglutide is FDA-approved for polycystic ovary syndrome. If a provider suggests either for PCOS, that’s an off-label use, and it’s a decision to make together.

Cost

What do metformin and semaglutide cost, every way to pay?

Metformin is the low-cost one by far. Here’s every price we confirmed on November 1, 2026.

Prices from GoodRx, NovoCare’s terms, wegovy.com and Medicare.gov, checked November 1, 2026; the $675 list price from Novo Nordisk (February 24, 2026) and Medicare’s $274 from CMS. NexLife’s price is the same at every dose. Compounded semaglutide online runs a median $199 a month, month to month and all in, across the 27 programs in our GLP-1 price index that publish a month-to-month price (checked Nov. 4, 2026).
How you payA monthA year, or what to know
Generic metformin, Walmart’s price on GoodRx (no coupon needed)60 tablets of 500 mg: a month at the starting dose$9The starting dose; a higher dose takes more or stronger tablets
Ozempic, NovoCare self-pay0.25 mg to 1 mg; a month is 28 days$349$4,537 (13 fills)
Ozempic 2 mg, NovoCare self-pay$499$6,487 (13 fills)
Ozempic tablets, NovoCare self-pay30 tablets; for type 2 diabetes$149 to $299, by dose$2,388 at 4 mg or $3,588 at 9 mg, the maintenance doses
Ozempic, new patientsfirst two fills at 0.25 or 0.5 mg$199 eachPrescription written and received by December 31, 2026; shipped by January 31, 2027
Ozempic with Part Dfor type 2 diabetesYour plan’s copay or coinsuranceFrom January 1, 2027, Medicare pays $274 for a 30-day supply
List price, from January 1, 2027Ozempic, Wegovy and Rybelsus$675Matters if your costs follow list price
Wegovy, NovoCare self-payfor weight, not blood-sugar control$349 pen ($399 HD); pill $149 to $299Pen $4,537 (13 fills)
Medicare GLP-1 BridgeWegovy, if you qualify; not with type 2 diabetes$50Through December 31, 2027
Compounded semaglutide, NexLife12-month plan; not FDA-approved$95$1,140
Compounded semaglutide, NexLifemonth to month; not FDA-approved$109$1,308

NexLife Price Match Guarantee†. Already on compounded semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

Swipe the table sideways to see every column.

Prices from GoodRx, NovoCare’s terms, wegovy.com and Medicare.gov, checked November 1, 2026; the $675 list price from Novo Nordisk (February 24, 2026) and Medicare’s $274 from CMS. NexLife’s price is the same at every dose. Compounded semaglutide online runs a median $199 a month, month to month and all in, across the 27 programs in our GLP-1 price index that publish a month-to-month price (checked Nov. 4, 2026).

The gap, in numbers. A year of Wegovy pens, the semaglutide approved for weight loss, is 13 four-week fills at $349, or $4,537. Compounded semaglutide at NexLife is $1,140 a year on the 12-month plan, $3,397 less. They’re different products: compounded semaglutide isn’t FDA-approved, isn’t a generic and isn’t Wegovy.

“Compounded drugs are not FDA-approved. This means the agency does not review their safety, effectiveness or quality before they are marketed.”

U.S. Food and Drug Administration, Understanding the Risks of Compounded Drugs

Insured but paying yourself? NovoCare’s self-pay price is open to you, Medicare included, but it can’t be billed to insurance or counted toward a deductible. More: Wegovy price 2027.

Already paying less for compounded semaglutide? NexLife matches the regular monthly price you pay another licensed U.S. telehealth provider. Price Match Guarantee†

Side effects

Metformin vs. semaglutide side effects, including vitamin B12

Both mostly affect the stomach. Metformin’s label adds a vitamin B12 warning; semaglutide’s adds a thyroid warning from rodent studies.

Not head-to-head. Metformin: a 29-week U.S. trial, 141 people on metformin and 145 on placebo (the Glucophage label, May 2018). Ozempic: two placebo-controlled trials, 521 people on Ozempic for an average of 32.9 weeks (its label, May 2026, Table 1). These trials studied FDA-approved Ozempic; compounded semaglutide wasn’t studied.
Side effectMetformin vs placeboOzempic 0.5 mg / 1 mg vs placebo
Diarrhea53% vs 12%8.5% / 8.8% vs 1.9%
Nauseametformin’s trial counted nausea and vomiting together26% vs 8%15.8% / 20.3% vs 6.1%
VomitingCounted with nausea5% / 9.2% vs 2.3%
Gasflatulence12% vs 6%Not in the main table
Weaknessasthenia9% vs 6%Not in the main table
Belly pain or discomfort6% vs 5%7.3% / 5.7% vs 4.6%
ConstipationNot in the main table5% / 3.1% vs 1.5%
Stopped because of itDiarrhea: 6%A stomach reaction: 3.1% / 3.8% vs 0.4%

Swipe the table sideways to see every column.

Not head-to-head. Metformin: a 29-week U.S. trial, 141 people on metformin and 145 on placebo (the Glucophage label, May 2018). Ozempic: two placebo-controlled trials, 521 people on Ozempic for an average of 32.9 weeks (its label, May 2026, Table 1). These trials studied FDA-approved Ozempic; compounded semaglutide wasn’t studied.

Vitamin B12. In 29-week trials, about 7% of people on metformin had a normal B12 level fall below normal, its label says. It advises blood counts every year and a B12 check every 2 to 3 years. Ozempic’s label lists no B12 warning.

Higher doses. In Ozempic’s 2 mg trial (SUSTAIN FORTE, 2021), 34% had a stomach side effect on 2 mg, against 30.8% on 1 mg. Ideas that help with meals: what to eat on a GLP-1.

Who shouldn’t

Who shouldn’t take metformin or semaglutide?

Each has a boxed warning and a short list of people who shouldn’t take it. Here they are, from the labels.

From the metformin label (Glucophage, revised May 2018) and the Ozempic label (revised May 2026). Wegovy’s carries the same boxed warning. Your provider reviews your history against the full labels.
MetforminSemaglutide (Ozempic, Wegovy)
Boxed warningLactic acidosis, which can be fatal. Risk rises with kidney or liver problems, age 65 or older, contrast dye, surgery, low oxygen and heavy drinkingThyroid C-cell tumors in rodents. It isn’t known whether semaglutide causes them in people
Don’t take it ifYour eGFR is below 30, you have metabolic acidosis such as diabetic ketoacidosis, or you’re allergic to itYou or a family member had medullary thyroid carcinoma, you have MEN 2, or you’ve had a serious allergy to semaglutide
Kidneys and scanseGFR checked before you start and periodically; paused around some contrast-dye scansDehydration from vomiting or diarrhea can injure the kidneys
PregnancyData are too limited to show a risk; poorly controlled diabetes carries its own risksStop at least 2 months before a planned pregnancy
Other label warningsLow B12; low blood sugar with insulin or a sulfonylureaPancreatitis, gallbladder disease, low blood sugar with insulin or a sulfonylurea, eye changes in type 2 diabetes, allergic reactions, and stomach contents entering the lungs under anesthesia

Swipe the table sideways to see every column.

From the metformin label (Glucophage, revised May 2018) and the Ozempic label (revised May 2026). Wegovy’s carries the same boxed warning. Your provider reviews your history against the full labels.

When to get help right away. Lactic acidosis is an emergency. It often starts with vague symptoms, such as feeling unwell, muscle pain, trouble breathing, unusual sleepiness or belly pain, its label says, and severe cases can bring low body temperature, low blood pressure and a slow heartbeat. Get emergency care: the label calls for stopping metformin and treatment in a hospital. On semaglutide, stop and call your provider for severe stomach pain that won’t go away, a possible sign of pancreatitis. Tell them about a lump in your neck, hoarseness or trouble swallowing. For a serious allergic reaction, call 911.

At NexLife

Choosing compounded semaglutide? What you get at NexLife

The price is the same at every dose, and a licensed provider decides if it’s right for you. NexLife’s providers prescribe compounded semaglutide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace metformin, Ozempic or your diabetes care.

  1. One price at every dose

    $95 a month on the 12-month plan, $99 on 6 months, $105 on 3 months or $109 month to month. No membership fee, and your price doesn’t rise with your dose. Compounded semaglutide isn’t FDA-approved or a generic, and a licensed provider prescribes it only when it offers a significant difference for you.

  2. Care from a licensed provider

    You start with an online assessment of about 3 minutes. A licensed provider reviews your health history and prescribes only if it’s right for you. Not prescribed? No charge for medication.

  3. Two named pharmacies

    One of two state-licensed 503A partner pharmacies fills your prescription: Absolute Pharmacy in Lutz, FL, or Boudreaux’s New Drug Store in Lake Charles, LA. Questions about your order come to us, not to them.

  4. Paying, shipping and support

    HSA or FSA card (we provide a letter of medical necessity), or Affirm, Klarna or Afterpay. With Medicare, you can pay yourself. Shipping is free, your pharmacy usually ships within 1 to 2 business days, and real people answer 24/7 at (949) 818-8000.

Switching from another program? We match the regular monthly price you pay another licensed U.S. telehealth provider for compounded semaglutide. Price Match Guarantee†

Who’s behind your care. Our medical director is Adam Kennah, MD, board-certified in emergency medicine by the American Board of Emergency Medicine. More: compounded semaglutide, explained.

Vial math

How many units is your semaglutide dose?

It depends on your vial’s strength. Here are the Wegovy label’s dose steps at two example strengths.

Semaglutide dose steps from the Wegovy label, with the volume and units on a U-100 syringe at two example strengths, 2.5 mg/mL and 5 mg/mL
WeeksWeekly doseAt 2.5 mg/mLAt 5 mg/mL
1 to 40.25 mg0.1 mL (10 units)0.05 mL (5 units)
5 to 80.5 mg0.2 mL (20 units)0.1 mL (10 units)
9 to 121 mg0.4 mL (40 units)0.2 mL (20 units)
13 to 161.7 mg0.68 mL (68 units)0.34 mL (34 units)
17 onward2.4 mg0.96 mL (96 units)0.48 mL (48 units)

The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.

The dose steps are from the Wegovy label; both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart. Or enter your own vial’s strength in the semaglutide dosage calculator.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $115/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $129/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $95/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $109/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Metformin vs. semaglutide: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

Can you take metformin and semaglutide together?

For type 2 diabetes, yes, if your provider prescribes both: Ozempic was tested in people taking metformin in five of its label’s six blood-sugar trials. For weight loss without diabetes, metformin is off-label. Both labels tie low blood sugar to insulin and sulfonylureas, so your provider may lower those doses. Never change a dose on your own.

Can I take compounded semaglutide with metformin?

Only if a licensed provider decides it’s right for you. NexLife’s providers prescribe it for weight loss; it isn’t a treatment for type 2 diabetes and doesn’t replace metformin or your diabetes care. It isn’t FDA-approved and wasn’t studied in Ozempic’s trials. At NexLife it’s $95 a month on the 12-month plan, or $109 month to month, at every dose.

Can semaglutide replace metformin?

Sometimes, but that’s your provider’s call. Metformin and Ozempic are both approved for type 2 diabetes, and Ozempic was studied alone and added to metformin. Ozempic also has heart and kidney approvals that metformin lacks, while metformin costs far less. Compounded semaglutide isn’t a treatment for type 2 diabetes. Don’t stop metformin without talking to your provider first.

Do metformin and semaglutide cause low blood sugar?

Mainly when they’re combined with insulin or a sulfonylurea. Ozempic’s label says those raise the risk, including severe lows, and to consider lowering their dose. Metformin’s label says the same about insulin and drugs that push the body to release insulin. Ask your provider what to watch for.

Is metformin cheaper than semaglutide?

Generic metformin is $9 a month at the starting dose, no coupon needed (November 1, 2026). Brand-name semaglutide costs far more: Ozempic pens are $349 a month self-pay ($499 at 2 mg), or $4,537 a year. Medicare’s $50 Bridge price for Wegovy isn’t open to people with type 2 diabetes.

Is semaglutide better than metformin?

Not for everyone. In separate trials (SUSTAIN 1, 2017; STEP 1, 2021), semaglutide lowered weight more, and Ozempic is also approved to cut heart and kidney risks in some adults with type 2 diabetes. Metformin is a generic pill, in use since 1995, at $9 for a month’s starting dose. Your provider weighs your goals, kidneys, cost and history.

Does metformin or semaglutide affect vitamin B12?

Metformin can. In 29-week trials, about 7% of people on metformin saw a normal vitamin B12 level fall below normal, its label says. It advises a B12 check every 2 to 3 years and blood counts every year. Ozempic’s label lists no B12 warning.

Is metformin or semaglutide better for prediabetes?

Neither is FDA-approved for prediabetes. In the Diabetes Prevention Program (NEJM, 2002), metformin cut new cases of diabetes by 31% against placebo over about 2.8 years, and a lifestyle program by 58%. With Medicare, prediabetes and a BMI of 27 or more can qualify you for Wegovy through the GLP-1 Bridge.

Which has more side effects, metformin or semaglutide?

Both mostly affect the stomach. In metformin’s label trial, 53% had diarrhea, against 12% on placebo. On Ozempic 1 mg, 20.3% had nausea and 8.8% diarrhea, against 6.1% and 1.9% on placebo. The trials differed, so the rates aren’t directly comparable, and compounded semaglutide wasn’t studied.

How much weight do people lose on metformin vs. semaglutide?

In separate trials, far more on semaglutide. In metformin’s 29-week label trial, people lost 1.4 lb, against 2.4 lb on placebo. Ozempic lowered weight 3.8 to 4.7 kg at 30 weeks (SUSTAIN 1, 2017), and Wegovy 14.9% at 68 weeks (STEP 1, 2021). Compounded semaglutide wasn’t studied.

Is metformin or semaglutide approved for PCOS?

No. Neither metformin nor any semaglutide is FDA-approved for polycystic ovary syndrome (PCOS). If a provider suggests either for PCOS, that’s an off-label use, and it’s a decision you make together.

Is there a semaglutide pill, like metformin?

Yes. For type 2 diabetes, semaglutide comes as Ozempic tablets (new in 2026) and Rybelsus. For weight, there’s the Wegovy pill. Self-pay, Ozempic tablets and the Wegovy pill are each $149 to $299 a month, by dose. Metformin is a generic pill, in use since 1995.

Can you take metformin or semaglutide with kidney disease?

It depends on your kidneys, and your provider checks first. Metformin isn’t recommended to start at an eGFR of 30 to 45 and is stopped below 30. Ozempic’s label adds a use for cutting kidney risks in adults with type 2 diabetes and chronic kidney disease, but warns that dehydration from vomiting or diarrhea can injure the kidneys.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Labels, the DPP paper, prices and Medicare’s rules checked November 1, 2026.

  • How we checked. Every clinical fact here comes from the metformin label on DailyMed, the Ozempic, Ozempic tablets and Wegovy labels, the Diabetes Prevention Program paper and Novo Nordisk’s approval releases, read on November 1, 2026. Prices come from GoodRx, NovoCare’s terms and wegovy.com, and Medicare’s rules from Medicare.gov and CMS, checked the same day. Each trial result carries its trial, its length, its year and its source, and we don’t compare trials as if they were one. Ozempic, Wegovy and Rybelsus are trademarks of Novo Nordisk. NexLife isn’t affiliated with Novo Nordisk.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
  • How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves

Paying less elsewhere? We match it.†

You know the trade-offs. Next: a 3-minute check.

A licensed provider reviews your health history and decides if compounded semaglutide is right for you: $95 a month on the 12-month plan, or $109 month to month, at every dose.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 1, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Metformin hydrochloride tablets prescribing information (Epic Pharma), DailyMed, revised November 2019. Read November 1, 2026.
  2. Glucophage and Glucophage XR (metformin) prescribing information, FDA copy (revised May 2018). Read Nov. 12, 2026.
  3. Drugs@FDA: Glucophage (NDA 020357), approved March 3, 1995. Read Nov. 12, 2026.
  4. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. Abstract read Nov. 12, 2026.
  5. Ozempic (semaglutide) prescribing information, Novo Nordisk, revised May 2026. Read November 1, 2026.
  6. Ozempic (semaglutide) prescribing information, FDA copy (revised May 2026). Read Nov. 12, 2026.
  7. Ozempic and Rybelsus (semaglutide) tablets prescribing information, Novo Nordisk, revised January 2026. Read November 1, 2026.
  8. Rybelsus and Ozempic (semaglutide) tablets prescribing information, FDA copy (revised January 2026). Read Nov. 12, 2026.
  9. Novo Nordisk: FDA approves Ozempic tablets (February 4, 2026). Read November 1, 2026.
  10. SUSTAIN 1: once-weekly semaglutide monotherapy versus placebo in type 2 diabetes (PubMed record). Title checked November 1, 2026.
  11. Wegovy (semaglutide) prescribing information, Novo Nordisk, revised June 2026. Read November 1, 2026.
  12. Wegovy (semaglutide) prescribing information, FDA copy (revised June 2026). Read Nov. 12, 2026.
  13. Wegovy prescribing information, June 2021 (FDA). Read November 1, 2026.
  14. Novo Nordisk: FDA approval for Wegovy (June 4, 2021). Read November 1, 2026.
  15. Novo Nordisk: FDA approval of Ozempic (December 5, 2017). Read November 1, 2026.
  16. NovoCare Pharmacy: self-pay terms and prices (Ozempic and Wegovy). Read November 1, 2026.
  17. Novo Nordisk: What to pay for Wegovy. Checked November 1, 2026.
  18. GoodRx: metformin vs. Wegovy prices. Checked November 1, 2026.
  19. Medicare.gov: Weight loss drugs (the Medicare GLP-1 Bridge). Read Nov. 12, 2026.
  20. CMS: Medicare GLP-1 Bridge. Read November 1, 2026.
  21. Novo Nordisk: US list price reduction for Wegovy, Ozempic and Rybelsus (February 24, 2026). Read November 1, 2026.
  22. CMS: Medicare drug price negotiation, negotiated prices for 2027 (fact sheet). Read November 1, 2026.
  23. NexLife: GLP-1 price index. Compounded semaglutide prices checked November 1, 2026.
  24. NexLife: pricing, every plan.
  25. U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. Content current as of June 22, 2026; read November 2, 2026.